Leaderboards/Herpesvirus Infections and Treatments

Herpesvirus Infections and Treatments

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Sarfraz-ur- Rahman
University of Veterinary and Animal Sciences
2
Aida Peiró-Mestres
Departament de Salut
3
Adam Zuiani
BioNTech (United States)
4
Nicolás Luna
Universidad del Rosario
5
Chiranjibi Sitaula
The University of Melbourne
6
Michael Pomirchy
Stanford University
7
Emile Malembi Kibungu
Unknown
8
Varea Costello
Walter Reed National Military Medical Center
9
Riccardo Vernuccio
Institut Pasteur
10
Leonard Schuele
Erasmus MC

Papers

1
A multivalent mRNA monkeypox virus vaccine (BNT166) protects mice and macaques from orthopoxvirus disease
Cell|2024
147 cit.
2
Real-time PCR assay to detect the novel Clade Ib monkeypox virus, September 2023 to May 2024
Eurosurveillance|2024
68 cit.
3
Enhanced multi-level features for very high resolution remote sensing scene classification
Neural Computing and Applications|2024
31 cit.
4
Circulation, viral diversity and genomic rearrangement in mpox virus in the Netherlands during the 2022 outbreak and beyond
Journal of Medical Virology|2024
16 cit.
5
Emergence of Oropouche virus among international travelers: A growing concern in non-endemic areas
Enfermedades Infecciosas y Microbiología Clínica|2025
6 cit.
6
Publication in Microbiology Spectrum (2025) [6 citations, W4410891963]
Microbiology Spectrum|2025
6 cit.
7
Publication in Neural Computing and Applications (2024) [1 citation, W4401122433]
Neural Computing and Applications|2024
1 cit.
8
Publication in Enfermedades infecciosas y microbiologia clinica (English ed ) (2025) [W4410589098]
Enfermedades infecciosas y microbiologia clinica (English ed )|2025
0 cit.
9
Publication in Communications Medicine (2026) [W7165771849]
Communications Medicine|2026
0 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Marianna Cortese
Harvard University
2
Minoru Tanaka
The University of Tokyo
3
Youssef Rizk
Lebanese American University
4
Kathleen Dooling
Pfizer (United States)
5
Laurent Perez
Hôpital Orthopédique de la Suisse Romande
6
Jennifer Wilburn
NHS England
7
Placide Mbala‐Kingebeni
University of Kinshasa
8
Sarakay Johnson
Unknown
9
Jean-Jacques Muyembe
National Institute of Biomedical Research
10
Panayampalli S. Satheshkumar
Department of Human Services

Papers

1
Prevention and Treatment of Monkeypox
Drugs|2022
654 cit.
2
Intratumoral oncolytic herpes virus G47∆ for residual or recurrent glioblastoma: a phase 2 trial
Nature Medicine|2022
493 cit.
3
Epidemiologic and Clinical Characteristics of Monkeypox Cases — United States, May 17–July 22, 2022
MMWR Morbidity and Mortality Weekly Report|2022
388 cit.
4
Sustained human outbreak of a new MPXV clade I lineage in eastern Democratic Republic of the Congo
Nature Medicine|2024
356 cit.
5
Use of Recombinant Zoster Vaccine in Immunocompromised Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
MMWR Morbidity and Mortality Weekly Report|2022
236 cit.
6
A phase I/II study of triple-mutated oncolytic herpes virus G47∆ in patients with progressive glioblastoma
Nature Communications|2022
198 cit.
7
Epidemiological and clinical features of mpox during the clade Ib outbreak in South Kivu, Democratic Republic of the Congo: a prospective cohort study
The Lancet|2025
69 cit.
8
Co-circulation of monkeypox virus subclades Ia and Ib in Kinshasa Province, Democratic Republic of the Congo, July to August 2024
Eurosurveillance|2024
43 cit.
9
Clinical Manifestations of Varicella: Disease Is Largely Forgotten, but It's Not Gone
The Journal of Infectious Diseases|2022
37 cit.
10
Suspected and confirmed mpox cases in DR Congo: a retrospective analysis of national epidemiological and laboratory surveillance data, 2010–23
The Lancet|2025
37 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Lawrence Corey
Fred Hutch Cancer Center
2
Bernard Moss
National Institute of Allergy and Infectious Diseases
3
L. David Sibley
Washington University in St. Louis
4
Geoffrey L. Smith
University of Cambridge
5
John C. Boothroyd
Stanford University
6
David M. Knipe
Boston Biomedical Research Institute
7
David C. Johnson
Johnson & Johnson (United States)
8
Ann M. Arvin
Stanford University
9
Donald M. Coen
Harvard University
10
Lynn W. Enquist
Princeton University

Papers

1
Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.
Proceedings of the National Academy of Sciences|1986
2.1k cit.
2
Epidemiology and Outcome of Mould Infections in Hematopoietic Stem Cell Transplant Recipients
Clinical Infectious Diseases|2002
1.5k cit.
3
Toxoplasma gondii Comprises Three Clonal Lineages: Correlation of Parasite Genotype with Human Disease
The Journal of Infectious Diseases|1995
1.4k cit.
4
Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection
New England Journal of Medicine|1990
1.3k cit.
5
Experimental Therapy of Human Glioma by Means of a Genetically Engineered Virus Mutant
Science|1991
1k cit.
6
Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors
Blood|2002
953 cit.
7
Direct and sensitive detection of a pathogenic protozoan, Toxoplasma gondii, by polymerase chain reaction
Journal of Clinical Microbiology|1989
901 cit.
8
Virulent strains of Toxoplasma gondii comprise a single clonal lineage
Nature|1992
855 cit.
9
Herpes simplex virus turns off the TAP to evade host immunity
Nature|1995
798 cit.
10
Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques.
Molecular and Cellular Biology|1985
781 cit.

Reagents for Herpesvirus Infections and Treatments

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 60

PathScan® Phospho-Lck (Tyr505) Sandwich ELISA Kit

Cited in 8 papers
#7941$66,129,740
View Evidence →
Cell Signaling Technology

TPP2 Antibody

Cited in 7 papers
#14981$317
View Evidence →
Cell Signaling Technology

SINTBAD (D1A5) Rabbit Monoclonal Antibody

Cited in 7 papers
#8605$161,351
View Evidence →

🌟 All-Time

Most validated

Agilent/Dako

Herpes Simplex Virus type 1 antibody

Cited in 13 papers
#B0114
View Evidence →
Cell Signaling TechnologyEvidence 64

PathScan® Phospho-Tau (Ser214) Sandwich ELISA Kit

Cited in 10 papers
#44177$66,129,740
View Evidence →
Cell Signaling Technology

C/EBP Antibody Sampler Kit

Cited in 8 papers
#12814$650
View Evidence →